Detection of CpG Methylation in G-Quadruplex Forming Sequences Using G-Quadruplex Ligands.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
06 Dec 2021
Historique:
received: 29 10 2021
revised: 30 11 2021
accepted: 02 12 2021
entrez: 10 12 2021
pubmed: 11 12 2021
medline: 17 12 2021
Statut: epublish

Résumé

Genomic DNA methylation is involved in many diseases and is expected to be a specific biomarker for even the pre-symptomatic diagnosis of many diseases. Thus, a rapid and inexpensive detection method is required for disease diagnosis. We have previously reported that cytosine methylation in G-quadruplex (G4)-forming oligonucleotides develops different G4 topologies. In this study, we developed a method for detecting CpG methylation in G4-forming oligonucleotides based on the structural differences between methylated and unmethylated G4 DNAs. The differences in G4 topologies due to CpG methylation can be discriminated by G4 ligands. We performed a binding assay between methylated or unmethylated G4 DNAs and G4 ligands. The binding abilities of fluorescent G4 ligands to

Identifiants

pubmed: 34884964
pii: ijms222313159
doi: 10.3390/ijms222313159
pmc: PMC8658440
pii:
doi:

Substances chimiques

BCL2 protein, human 0
Ligands 0
Proto-Oncogene Proteins c-bcl-2 0
VEGFA protein, human 0
Vascular Endothelial Growth Factor A 0
DNA 9007-49-2
HRAS protein, human EC 3.6.5.2
Proto-Oncogene Proteins p21(ras) EC 3.6.5.2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Nucleic Acids Res. 2006 May 19;34(9):2723-35
pubmed: 16714449
Nat Genet. 2005 Aug;37(8):853-62
pubmed: 16007088
Front Mol Biosci. 2015 Apr 22;2:13
pubmed: 25988180
Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1827-31
pubmed: 1542678
Molecules. 2018 Apr 18;23(4):
pubmed: 29670067
Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1412-7
pubmed: 16432200
Cancer Cell. 2019 Oct 14;36(4):350-368
pubmed: 31614115
Nat Struct Mol Biol. 2018 Oct;25(10):951-957
pubmed: 30275516
Angew Chem Int Ed Engl. 2008;47(30):5557-60
pubmed: 18563772
Biosens Bioelectron. 2017 Jul 15;93:118-123
pubmed: 27666367
J Transl Med. 2012 Mar 06;10:36
pubmed: 22390413
Nat Rev Genet. 2013 Mar;14(3):204-20
pubmed: 23400093
Nucleic Acids Res. 2006 Jul 05;34(11):e82
pubmed: 16822855
J Med Chem. 2016 Jul 14;59(13):5987-6011
pubmed: 26840940
Epigenetics. 2015;10(2):135-41
pubmed: 25587773
Ann N Y Acad Sci. 2008 Aug;1137:1-6
pubmed: 18837917
Biochem Biophys Res Commun. 2013 Apr 19;433(4):368-73
pubmed: 23261425
Anal Chem. 2012 Oct 2;84(19):8259-64
pubmed: 22924825
Clin Epigenetics. 2020 Jul 6;12(1):100
pubmed: 32631437
Structure. 1993 Dec 15;1(4):263-82
pubmed: 8081740
Front Genet. 2019 Nov 14;10:1150
pubmed: 31803237
Angew Chem Int Ed Engl. 2013 Nov 11;52(46):12052-5
pubmed: 24150845
Nat Rev Cancer. 2011 Jun;11(6):426-37
pubmed: 21562580
Genes (Basel). 2019 Dec 23;11(1):
pubmed: 31877923
Clin Epigenetics. 2019 Sep 6;11(1):132
pubmed: 31492175
FEBS J. 2020 Feb;287(3):483-495
pubmed: 31532882
Nucleic Acids Res. 2006;34(19):5402-15
pubmed: 17012276
Cancer Res. 2006 Aug 15;66(16):7939-47
pubmed: 16912168
Nat Genet. 2016 Oct;48(10):1267-72
pubmed: 27618450
Cancer Res. 2001 Feb 15;61(4):1659-65
pubmed: 11245480
Anal Chem. 2016 Jul 19;88(14):7101-7
pubmed: 27351368
Nat Rev Cancer. 2003 Apr;3(4):253-66
pubmed: 12671664
Nucleic Acids Res. 2008 Aug;36(14):4598-608
pubmed: 18614607
Alzheimers Dement (Amst). 2020 Jul 09;12(1):e12056
pubmed: 32671182
PLoS One. 2011;6(9):e24421
pubmed: 21931711
Org Biomol Chem. 2021 Sep 29;19(37):8035-8040
pubmed: 34492672
Nucleic Acids Res. 2013 Dec;41(22):10584-92
pubmed: 24005038
World J Biol Psychiatry. 2016 Sep;17(6):449-56
pubmed: 27269479
Chembiochem. 2009 Feb 13;10(3):431-5
pubmed: 19140143
Proc Natl Acad Sci U S A. 1962 Dec 15;48:2013-8
pubmed: 13947099
Nucleic Acids Res. 2006;34(18):5133-44
pubmed: 16998187
Clin Epigenetics. 2019 Apr 5;11(1):59
pubmed: 30953539

Auteurs

Hijiri Hasegawa (H)

LG Japan Lab Inc., 4-13-14 Higashi Shinagawa, Shinagawa-ku, Tokyo 140-0002, Japan.

Ikkei Sasaki (I)

Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16 Naka-cho, Koganei, Tokyo 184-8588, Japan.

Kaori Tsukakoshi (K)

Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16 Naka-cho, Koganei, Tokyo 184-8588, Japan.

Yue Ma (Y)

Institute of Global Innovation Research, Tokyo University of Agriculture and Technology, 2-24-16 Naka-cho, Koganei, Tokyo 184-8588, Japan.

Kazuo Nagasawa (K)

Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16 Naka-cho, Koganei, Tokyo 184-8588, Japan.

Shusuke Numata (S)

Department of Psychiatry, Graduate School of Biomedical Sciences, Tokushima University, 3-8-15 Kuramoto-cho, Tokushima 770-8503, Japan.

Yuuki Inoue (Y)

LG Japan Lab Inc., 4-13-14 Higashi Shinagawa, Shinagawa-ku, Tokyo 140-0002, Japan.

Yeji Kim (Y)

LG Japan Lab Inc., 4-13-14 Higashi Shinagawa, Shinagawa-ku, Tokyo 140-0002, Japan.

Kazunori Ikebukuro (K)

Department of Biotechnology and Life Science, Tokyo University of Agriculture and Technology, 2-24-16 Naka-cho, Koganei, Tokyo 184-8588, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH